Interview with Robin Mansukhani CEO and Anil Bhushan Chief Scientist of Deciduous Therapeutics

Published: July 19, 2022, 4 a.m.

b'

Deciduous Therapeutics is a venture-backed startup developing novel immunotherapies to treat age-related diseases.

'